XML 56 R38.htm IDEA: XBRL DOCUMENT v3.25.1
Equity Plan Awards (Tables)
12 Months Ended
Dec. 31, 2024
Stock Based Compensation, Unamortized Stock-Based Compensation and Remaining Weighted Average Period

The below tables illustrate the Company’s stock-based compensation, unamortized stock-based compensation, and remaining weighted average period for the years ended December 31, 2024, 2023 and 2022. This projected expense will change if any stock options and restricted stock are granted or cancelled prior to the respective reporting periods, or if there are any changes required to be made for estimated forfeitures.

 

 

Stock-Based
Compensation

 

 

Unamortized
Stock-Based
Compensation

 

 

Remaining
Weighted
Average
Period (years)

 

December 31, 2024

 

 

 

 

 

 

 

 

 

Options

 

$

314

 

 

$

686

 

 

 

2.1

 

Restricted Stock

 

 

2,499

 

 

 

2,595

 

 

 

2.1

 

Unrestricted Stock

 

 

596

 

 

 

270

 

 

 

0.4

 

Performance-Based Restricted Stock

 

 

1,003

 

 

 

909

 

 

 

2.0

 

Total

 

$

4,412

 

 

$

4,460

 

 

 

 

December 31, 2023

 

 

 

 

 

 

 

 

 

Restricted Stock

 

$

4,830

 

 

$

6,593

 

 

 

1.8

 

Unrestricted Stock

 

 

520

 

 

 

217

 

 

 

0.4

 

Performance-Based Restricted Stock

 

 

788

 

 

 

2,500

 

 

 

1.8

 

Total

 

$

6,138

 

 

$

9,310

 

 

 

 

December 31, 2022

 

 

 

 

 

 

 

 

 

Restricted Stock

 

$

4,407

 

 

$

6,585

 

 

 

1.8

 

Unrestricted Stock

 

 

499

 

 

 

217

 

 

 

0.4

 

Performance-Based Restricted Stock

 

 

778

 

 

 

2,441

 

 

 

1.8

 

Total

 

$

5,684

 

 

$

9,243

 

 

 

 

 

Summary of Option Activity

Activity of the incentive stock option plans:

 

 

 

Number of
Shares

 

 

Weighted Average
Exercise Price Per
Share

 

Balance outstanding, January 1, 2022

 

 

108,036

 

 

$

11.49

 

Options exercised

 

 

(39,140

)

 

 

11.49

 

Balance outstanding, December 31, 2022

 

 

68,896

 

 

$

11.49

 

Options exercised

 

 

(4,024

)

 

 

11.49

 

Balance outstanding, December 31, 2023

 

 

64,872

 

 

$

11.49

 

Options granted

 

 

253,853

 

 

 

10.28

 

Options exercised

 

 

 

 

 

 

Options expired

 

 

(64,872

)

 

 

11.49

 

Balance outstanding, December 31, 2024

 

 

253,853

 

 

$

10.28

 

Performance Based Stock Options  
Summary of Option Activity

Activity of the performance incentive stock option plan:

 

 

Number of
Shares

 

 

Weighted
Average Exercise
Price Per
Share

 

 

Balance outstanding, January 1, 2022

 

 

81,808

 

 

$

11.49

 

 

Options exercised

 

 

 

 

 

11.49

 

 

Balance outstanding, December 31, 2023

 

 

81,808

 

 

$

11.49

 

 

Options granted

 

 

337,542

 

 

 

10.28

 

 

Options expired

 

 

(81,808

)

 

 

11.49

 

 

Options forfeited

 

 

(166,884

)

 

 

10.28

 

 

Balance outstanding, December 31, 2024

 

 

170,658

 

 

$

10.28

 

 

Restricted and Unrestricted Stock  
Summary of Non-Vested Shares

A summary of nonvested restricted and unrestricted stock is presented below:

 

 

 

2024

 

 

2023

 

 

2022

 

 

 

Number
of Shares

 

 

Weighted
Average
Grant
Date Fair
Value

 

 

Number
of Shares

 

 

Weighted
Average
Grant
Date Fair
Value

 

 

Number
of Shares

 

 

Weighted
Average
Grant
Date Fair
Value

 

Nonvested shares at January 1st

 

 

686,185

 

 

$

21.24

 

 

 

742,050

 

 

$

18.86

 

 

 

817,290

 

 

$

17.04

 

Granted

 

 

238,585

 

 

 

7.65

 

 

 

306,515

 

 

 

20.31

 

 

 

256,417

 

 

 

23.53

 

Vested

 

 

(348,934

)

 

 

17.65

 

 

 

(319,751

)

 

 

14.90

 

 

 

(262,521

)

 

 

17.84

 

Forfeited

 

 

(144,611

)

 

 

19.55

 

 

 

(42,629

)

 

 

20.61

 

 

 

(69,136

)

 

 

18.58

 

Nonvested shares at December 31st

 

 

431,225

 

 

$

17.20

 

 

 

686,185

 

 

$

21.24

 

 

 

742,050

 

 

$

18.86

 

The total grant-date fair value of stocks vested during the years ended December 31, 2024, 2023, and 2022 were $6,158, $4,763, and $4,685, respectively.

Performance Based Restricted Stock  
Summary of Non-Vested Shares

A summary of nonvested performance-based stock is presented below:

 

 

 

December 31, 2024

 

 

December 31, 2023

 

 

December 31, 2022

 

 

 

Number
of Shares

 

 

Weighted
Average
Grant
Date Fair
Value

 

 

Number
of Shares

 

 

Weighted
Average
Grant
Date Fair
Value

 

 

Number
of Shares

 

 

Weighted
Average
Grant
Date Fair
Value

 

Nonvested shares at January 1st

 

 

263,325

 

 

$

21.37

 

 

 

318,699

 

 

$

18.05

 

 

 

379,061

 

 

$

16.43

 

Granted

 

 

177,010

 

 

 

2.13

 

 

 

94,028

 

 

 

21.51

 

 

 

83,190

 

 

 

23.63

 

Change based on performance achievement

 

 

(49,806

)

 

 

19.81

 

 

 

(58,827

)

 

 

14.73

 

 

 

(68,484

)

 

 

16.87

 

Vested

 

 

(80,570

)

 

 

21.51

 

 

 

(86,188

)

 

 

13.99

 

 

 

(51,308

)

 

 

17.09

 

Forfeited

 

 

(58,331

)

 

 

22.23

 

 

 

(4,387

)

 

 

17.67

 

 

 

(23,760

)

 

 

17.21

 

Nonvested shares at December 31st

 

 

251,628

 

 

$

7.90

 

 

 

263,325

 

 

$

21.37

 

 

 

318,699

 

 

$

18.05

 

The total grant-date fair value of stocks vested during the years ended December 31, 2024, 2023, and 2022 were $1,733, $1,206, and $877, respectively.